Frontiers in Medicine (Sep 2022)

A multidisciplinary approach to the diagnosis of antisynthetase syndrome

  • Matthew Wells,
  • Sughra Alawi,
  • Kyaing Yi Mon Thin,
  • Harsha Gunawardena,
  • Harsha Gunawardena,
  • Adrian R. Brown,
  • Anthony Edey,
  • John D. Pauling,
  • John D. Pauling,
  • Shaney L. Barratt,
  • Huzaifa I. Adamali

DOI
https://doi.org/10.3389/fmed.2022.959653
Journal volume & issue
Vol. 9

Abstract

Read online

Antisynthetase syndrome is a subtype of idiopathic inflammatory myopathy, strongly associated with the presence of interstitial lung disease. Diagnosis is made by identifying myositis-specific antibodies directed against aminoacyl tRNA synthetase, and relevant clinical and radiologic features. Given the multisystem nature of the disease, diagnosis requires the careful synthesis of subtle clinical and radiological features with the interpretation of specialized autoimmune serological testing. This is provided in a multidisciplinary environment with input from rheumatologists, respiratory physicians, and radiologists. Differentiation from other idiopathic interstitial lung diseases is key; treatment and prognosis differ between patients with antisynthetase syndrome and idiopathic interstitial lung disease. In this review article, we look at the role of the multidisciplinary team and its individual members in the initial diagnosis of the antisynthetase syndrome, including the role of physicians, radiologists, and the wider team.

Keywords